ARGONAUTE RNA LIMITED

Active Cardiff

Research and experimental development on biotechnology

8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

ARGONAUTE RNA LIMITED

Research and experimental development on biotechnology

Founded 21 Jul 2015 Active Cardiff, Wales 8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 20 Mar 2026 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 10 Jul 2025 Next due 26 Jun 2026 1 month remaining
Net assets £827K £825K 2025 year on year
Total assets £908K £1M 2025 year on year
Total Liabilities £82K £282K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Cardiff Business Technology Centre Senghennydd Road Cardiff CF24 4AY Wales

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ARGONAUTE RNA LIMITED (09694988), an active life sciences and medical technology company based in Cardiff, Wales. Incorporated 21 Jul 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2016–2025)

Cash in Bank

£259.58k

Decreased by £1.11M (-81%)

Net Assets

£826.62k

Decreased by £825.25k (-50%)

Total Liabilities

£81.75k

Decreased by £282.33k (-78%)

Turnover

N/A

Employees

8

Increased by 2 (+33%)

Debt Ratio

9%

Decreased by 9 (-50%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jul 2021Seed, Growth/Late Stage
Investor 3Jul 2021Seed, Growth/Late Stage
Investor 5Jul 2021Growth/Late Stage

Share Capital

Share Capital

Share allotments and capital structure

10 Allotments 2,843,895 Shares £6.23m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
25 Feb 2026440,039£964k£2.19
25 Oct 2024526,274£1.15m£2.19
25 Apr 2024675,781£1.48m£2.19
25 Apr 2024120,421£264k£2.19
8 Jan 2023376,250£824k£2.19

Officers

Officers

2 active 1 resigned
Status
David William Dawson BallDirectorBritishEngland577 Jul 2020Active
Michael Mohamed Tarik KhanDirectorBritishEngland667 Jul 2020Active

Shareholders

Shareholders (88)

Anthony Parker
16.7%
781,000
Richard Tompkins
16.7%
781,000

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Richard Michael Tompkins

Ceased 8 Jan 2023

Ceased

Anthony Michael Parker

Ceased 8 Jan 2023

Ceased

Group Structure

Group Structure

ARGONAUTE RNA LIMITED Current Company
INVERPHARMA LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
18 Apr 2026ResolutionResolutions
18 Apr 2026ResolutionResolutions
20 Mar 2026AccountsAnnual accounts made up to 31 Dec 2025
11 Mar 2026CapitalAllotment of shares (GBP 327.919168) on 25 Feb 2026
10 Jul 2025Confirmation StatementConfirmation statement made on 12 Jun 2025 with updates
18 Apr 2026 Resolution

Resolutions

18 Apr 2026 Resolution

Resolutions

20 Mar 2026 Accounts

Annual accounts made up to 31 Dec 2025

11 Mar 2026 Capital

Allotment of shares (GBP 327.919168) on 25 Feb 2026

10 Jul 2025 Confirmation Statement

Confirmation statement made on 12 Jun 2025 with updates

Recent Activity

Latest Activity

Resolutions

4 weeks ago on 18 Apr 2026

Resolutions

4 weeks ago on 18 Apr 2026

Annual accounts made up to 31 Dec 2025

1 months ago on 20 Mar 2026

Allotment of shares (GBP 327.919168) on 25 Feb 2026

2 months ago on 11 Mar 2026

Confirmation statement made on 12 Jun 2025 with updates

10 months ago on 10 Jul 2025